SMMT
Summit Therapeutics Inc.
There isn't enough reported data to score SMMT yet.
SMMT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
SMMT's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
SMMT PE Valuation
SMMT has no meaningful PE right now: it lost money over the past year.
SMMT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| -- | |
| Limited | |
| Low |
Analysts expect SMMT's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.
SMMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.06 | +$0.18 |
| Q2 2026 | -$1.11 | -$0.10 |
| Q1 2026 | -$1.59 | -$1.25 |
| Q4 2025 | -$1.44 | -$1.13 |
| Q3 2025 | -$1.24 | -$0.96 |
| Q2 2025 | -$1.01 | -$0.78 |
| Q1 2025 | -$0.34 | -$0.18 |
| Q4 2024 | -$0.31 | +$1.22 |
SMMT lost $1.06 per share over the past year, a smaller loss than the year before.
SMMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2022 | $220K | -83% |
| Q2 2022 | $235K | +312% |
| Q1 2022 | $250K | +30% |
| Q4 2021 | $251K | +36% |
| Q3 2021 | $1.3M | +623% |
SMMT's revenue has slid since its 2021 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2022 | -7700% | -6211 points |
| Q2 2022 | -5401% | +36231 points |
| Q1 2022 | -8863% | -49 points |
| Q4 2021 | -10377% | -3054 points |
| Q3 2021 | -1489% | +8576 points |
| Q2 2021 | -41632% | N/A |
| Q1 2021 | -8814% | N/A |
| Q4 2020 | -7324% | N/A |
SMMT's operating margin was −7700% last quarter, down 6211 points from the same quarter a year ago.
SMMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$160.2M | -$67.1M |
| Q2 2026 | -$142M | -$75.3M |
| Q1 2026 | -$122.5M | -$60.9M |
| Q4 2025 | -$102.1M | -$53.4M |
| Q3 2025 | -$93.2M | -$62.8M |
| Q2 2025 | -$66.7M | -$33.7M |
| Q1 2025 | -$61.6M | -$31.5M |
| Q4 2024 | -$48.7M | -$29.2M |
SMMT has burned cash in almost every quarter: −$527M over the past year, against −$270M the year before.
SMMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.6% | +20M shares |
| 1 year | +7.4% | +54.8M shares |
| 3 years | +14% | +100M shares |
| 5 years | +781% | +708M shares |
SMMT has 798M diluted shares, up 7.4% from a year ago.
SMMT Net Leverage
SMMT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SMMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.2 | Neutral |
| Stochastic | 53.3 | Neutral |
SMMT's weekly RSI is 47 (neutral) and its Stochastic is 53 (neutral).
SMMT PE vs Healthcare Sector
SMMT has no meaningful PE right now: it lost money over the past year.
SMMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.9 | 5.5% below |
| 20 week MA | $15.3 | 1.4% below |
| 50 week MA | $16.3 | 7.8% below |
| 100 week MA | $19.0 | 21% below |
| 200 week MA | $12.6 | 19% above |
SMMT has fallen below most of its moving averages, though it's still 19% above its 200-week average.
SMMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.55 | $5.70 | +268% |
| 2021 | $5.70 | $3.03 | -47% |
| 2022 | $3.03 | $3.67 | +21% |
| 2023 | $3.67 | $2.61 | -29% |
| 2024 | $2.61 | $18.2 | +598% |
| 2025 | $18.2 | $18.1 | -0.4% |
| 2026 YTD | $18.1 | $15.1 | -17% |
SMMT's yearly returns have swung widely, from +598% in 2024 to −47% in 2021. It's down 17% so far in 2026.